Cargando…
Virtual Screening of Repurposed Drugs as Potential Spike Protein Inhibitors of Different SARS-CoV-2 Variants: Molecular Docking Study
Like most of the RNA viruses, SARS-CoV-2 continuously mutates. Although many mutations have an insignificant impact on the virus properties, mutations in the surface protein, especially those in the receptor-binding domain, may lead to immune or vaccine escape variants, or altered binding activities...
Autores principales: | Eweas, Ahmad F., Osman, Hosam-Eldin H., Naguib, Ibrahim A., Abourehab, Mohammed A. S., Abdel-Moneim, Ahmed S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319331/ https://www.ncbi.nlm.nih.gov/pubmed/35877432 http://dx.doi.org/10.3390/cimb44070208 |
Ejemplares similares
-
Molecular Docking Reveals Ivermectin and Remdesivir as Potential Repurposed Drugs Against SARS-CoV-2
por: Eweas, Ahmad F., et al.
Publicado: (2021) -
Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities
por: Shawky, Ahmed M., et al.
Publicado: (2020) -
Screening of potential inhibitors of COVID-19 with repurposing approach via molecular docking
por: Alizadehmohajer, Negin, et al.
Publicado: (2022) -
Docking-based virtual screening of known drugs against murE of Mycobacterium tuberculosis towards repurposing for TB
por: Brindha, Sridharan, et al.
Publicado: (2016) -
In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing
por: Mohamed, Eslam A. R., et al.
Publicado: (2023)